204 related articles for article (PubMed ID: 33621266)
1. Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity.
Cox RM; Sourimant J; Govindarajan M; Natchus MG; Plemper RK
PLoS Pathog; 2021 Feb; 17(2):e1009371. PubMed ID: 33621266
[TBL] [Abstract][Full Text] [Related]
2. Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokinetics.
Ndungu JM; Krumm SA; Yan D; Arrendale RF; Reddy GP; Evers T; Howard R; Natchus MG; Saindane MT; Liotta DC; Plemper RK; Snyder JP; Sun A
J Med Chem; 2012 May; 55(9):4220-30. PubMed ID: 22480182
[TBL] [Abstract][Full Text] [Related]
3. Target analysis of the experimental measles therapeutic AS-136A.
Yoon JJ; Krumm SA; Ndungu JM; Hoffman V; Bankamp B; Rota PA; Sun A; Snyder JP; Plemper RK
Antimicrob Agents Chemother; 2009 Sep; 53(9):3860-70. PubMed ID: 19528268
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding.
Wittwer K; Anderson DE; Pfeffermann K; Cox RM; Wolf JD; Santibanez S; Mankertz A; Plesker R; Sticher ZM; Kolkykhalov AA; Natchus MG; Pfaller CK; Plemper RK; von Messling V
Nat Commun; 2021 Sep; 12(1):5233. PubMed ID: 34475387
[TBL] [Abstract][Full Text] [Related]
5. ERDRP-0519 inhibits feline coronavirus in vitro.
Camero M; Lanave G; Catella C; Lucente MS; Sposato A; Mari V; Tempesta M; Martella V; Buonavoglia A
BMC Vet Res; 2022 Jan; 18(1):55. PubMed ID: 35078478
[TBL] [Abstract][Full Text] [Related]
6. Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity.
White LK; Yoon JJ; Lee JK; Sun A; Du Y; Fu H; Snyder JP; Plemper RK
Antimicrob Agents Chemother; 2007 Jul; 51(7):2293-303. PubMed ID: 17470652
[TBL] [Abstract][Full Text] [Related]
7. Design and Execution of In Vitro Polymerase Assays for Measles Virus and Related Mononegaviruses.
Cox RM; Plemper RK
Methods Mol Biol; 2024; 2808():19-33. PubMed ID: 38743360
[TBL] [Abstract][Full Text] [Related]
8. Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex.
Sun A; Yoon JJ; Yin Y; Prussia A; Yang Y; Min J; Plemper RK; Snyder JP
J Med Chem; 2008 Jul; 51(13):3731-41. PubMed ID: 18529043
[TBL] [Abstract][Full Text] [Related]
9. The Unstructured Paramyxovirus Nucleocapsid Protein Tail Domain Modulates Viral Pathogenesis through Regulation of Transcriptase Activity.
Thakkar VD; Cox RM; Sawatsky B; da Fontoura Budaszewski R; Sourimant J; Wabbel K; Makhsous N; Greninger AL; von Messling V; Plemper RK
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437959
[TBL] [Abstract][Full Text] [Related]
10. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model.
Krumm SA; Yan D; Hovingh ES; Evers TJ; Enkirch T; Reddy GP; Sun A; Saindane MT; Arrendale RF; Painter G; Liotta DC; Natchus MG; von Messling V; Plemper RK
Sci Transl Med; 2014 Apr; 6(232):232ra52. PubMed ID: 24739760
[TBL] [Abstract][Full Text] [Related]
11. Viral evolution identifies a regulatory interface between paramyxovirus polymerase complex and nucleocapsid that controls replication dynamics.
Sourimant J; Thakkar VD; Cox RM; Plemper RK
Sci Adv; 2020 Mar; 6(10):eaaz1590. PubMed ID: 32181359
[TBL] [Abstract][Full Text] [Related]
12. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
13.
Cao D; Gao Y; Roesler C; Rice S; D'Cunha P; Zhuang L; Slack J; Antonova A; Romanelli S; Liang B
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028717
[TBL] [Abstract][Full Text] [Related]
14. Antiviral Screen against Canine Distemper Virus-Induced Membrane Fusion Activity.
Shrestha N; Gall FM; Vesin J; Chambon M; Turcatti G; Fotiadis D; Riedl R; Plattet P
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477492
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.
Sleeman K; Stein DA; Tamin A; Reddish M; Iversen PL; Rota PA
Virus Res; 2009 Mar; 140(1-2):49-56. PubMed ID: 19059443
[TBL] [Abstract][Full Text] [Related]
16. The measles virus nucleocapsid protein tail domain is dispensable for viral polymerase recruitment and activity.
Krumm SA; Takeda M; Plemper RK
J Biol Chem; 2013 Oct; 288(41):29943-53. PubMed ID: 24003217
[TBL] [Abstract][Full Text] [Related]
17. Measles Virus Fusion Protein: Structure, Function and Inhibition.
Plattet P; Alves L; Herren M; Aguilar HC
Viruses; 2016 Apr; 8(4):112. PubMed ID: 27110811
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets.
Cox RM; Wolf JD; Lieberman NA; Lieber CM; Kang HJ; Sticher ZM; Yoon JJ; Andrews MK; Govindarajan M; Krueger RE; Sobolik EB; Natchus MG; Gewirtz AT; deSwart RL; Kolykhalov AA; Hekmatyar K; Sakamoto K; Greninger AL; Plemper RK
Nat Commun; 2024 Feb; 15(1):1189. PubMed ID: 38331906
[TBL] [Abstract][Full Text] [Related]
19. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
[TBL] [Abstract][Full Text] [Related]
20. Primary resistance mechanism of the canine distemper virus fusion protein against a small-molecule membrane fusion inhibitor.
Kalbermatter D; Shrestha N; Ader-Ebert N; Herren M; Moll P; Plemper RK; Altmann KH; Langedijk JP; Gall F; Lindenmann U; Riedl R; Fotiadis D; Plattet P
Virus Res; 2019 Jan; 259():28-37. PubMed ID: 30296457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
